• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bioxytran Inc (OP:BIXT)

0.0470 -0.0005 (-1.05%)
Streaming Delayed Price Updated: 12:21 PM EST, Jan 29, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Bioxytran Inc

News headline image
Bioxytran Provides Corporate Update Highlighting Momentum Across Its Multi-Platform Pipeline
January 29, 2026
From Bioxytran
Via ACN Newswire
News headline image
Bioxytran Provides Corporate Update Highlighting Momentum Across Its Multi-Platform Pipeline
January 29, 2026
Via Press Release Distribution Service
News headline image
Bioxytran Marks 50 years of Mitochondrial Research with BXT-25 Advancements
April 09, 2025
Via Get News
News headline image
Bioxytran's Medical Breakthrough in Fighting All Viruses
September 19, 2024
Via ACCESSWIRE
News headline image
Bioxytran Establishes Indian Subsidiary in Preparation of Commercialization
December 14, 2022
From BIOXYTRAN, INC.
Via GlobeNewswire
News headline image
Bioxytran Interview at the Emerging Growth Conference
December 12, 2022
From BIOXYTRAN, INC.
Via GlobeNewswire
News headline image
Bioxytran Receives Approval to Optimize Dosage in COVID-19 Patients
December 08, 2022
From BIOXYTRAN, INC.
Via GlobeNewswire
News headline image
Bioxytran, Inc. Announces the Reinitiation of Coverage of Its Stock by Avise Analytics
November 22, 2022
From BIOXYTRAN, INC.
Via GlobeNewswire
While COVID-19 Drags On, Biotechs Introduce New Treatments & Vaccines to Combat Subvariants
November 16, 2022
EQNX::TICKER_START (OTCQB:BIXT),(NASDAQ:NVAX),(NYSE:PFE),(NASDAQ:MRNA),(NASDAQ:INO),(NASDAQ:BNTX) EQNX::TICKER_END 
Via FinancialNewsMedia
Bioxytran Releases Positive Top-line Results from Phase 2 Trial of Galectin Antagonist on COVID-19 Patients in medRxiv Pre-print
November 16, 2022
Complete elimination of viral load in 100% of patients at day 7 vs 6% in placebo (p=.001) Complete elimination of viral load in 88% of patients at day 3 vs 0% in placebo (p=.001) Treated population... 
Via FinancialNewsMedia
News headline image
Bioxytran Scientific Advisor Releases New Book on Brain Metabolism
October 25, 2022
From BIOXYTRAN, INC.
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap